Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rimmer

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Rhinology|August 4, 2019
European position paper on diagnostic tools in rhinologyJ Rimmer, P Hellings, V J Lund, et al.
The Journal of Clinical Endocrinology and Metabolism|March 2, 2013
Whole-exome sequencing studies of nonfunctioning pituitary adenomasPaul J Newey, M Andrew Nesbit, Andrew J Rimmer, et al.
Nature Genetics|December 11, 2012
Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3M Andrew Nesbit, Fadil M Hannan, Sarah A Howles, et al.
Plos Genetics|February 6, 2013
Unlocking the bottleneck in forward genetics using whole-genome sequencing and identity by descent to isolate causative mutationsKatherine R Bull, Andrew J Rimmer, Owen M Siggs, et al.
The Journal of Experimental Medicine|December 26, 2012
B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2AHannes Bergmann, Mehmet Yabas, Alanna Short, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to diseaseBernadette C Young, Tanya Golubchik, Elizabeth M Batty, et al.
Rhinology|September 29, 2020
EUFOREA treatment algorithm for allergic rhinitisP W Hellings, G Scadding, C Bachert, et al.
Internal Medicine Journal|June 29, 2016
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair RegistryP G Gibson, H Reddel, V M McDonald, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 6, 2016
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteriaM Hew, A Gillman, M Sutherland, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2018
Working while unwell: Workplace impairment in people with severe asthmaS A Hiles, E S Harvey, V M McDonald, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Rhinology|August 4, 2019
European position paper on diagnostic tools in rhinologyJ Rimmer, P Hellings, V J Lund, et al.
The Journal of Clinical Endocrinology and Metabolism|March 2, 2013
Whole-exome sequencing studies of nonfunctioning pituitary adenomasPaul J Newey, M Andrew Nesbit, Andrew J Rimmer, et al.
Nature Genetics|December 11, 2012
Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3M Andrew Nesbit, Fadil M Hannan, Sarah A Howles, et al.
Plos Genetics|February 6, 2013
Unlocking the bottleneck in forward genetics using whole-genome sequencing and identity by descent to isolate causative mutationsKatherine R Bull, Andrew J Rimmer, Owen M Siggs, et al.
The Journal of Experimental Medicine|December 26, 2012
B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2AHannes Bergmann, Mehmet Yabas, Alanna Short, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to diseaseBernadette C Young, Tanya Golubchik, Elizabeth M Batty, et al.
Rhinology|September 29, 2020
EUFOREA treatment algorithm for allergic rhinitisP W Hellings, G Scadding, C Bachert, et al.
Internal Medicine Journal|June 29, 2016
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair RegistryP G Gibson, H Reddel, V M McDonald, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 6, 2016
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteriaM Hew, A Gillman, M Sutherland, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2018
Working while unwell: Workplace impairment in people with severe asthmaS A Hiles, E S Harvey, V M McDonald, et al.
Pageof 14